Inhibition of the constitutively active Jak/STAT3 in gastric tumor leads to reduced polymorphonuclear inflammation and inhibition of pro-inflammatory cytokines IL-11, IL-6 and IL-1β and reduction of tumor volume in mice [84]. This evidence concerns the gene IL6 and neoplasm.